The project "Research and Development of an Advanced Formulation for Alveolar Ridge Augmentation - OSTEOproDENT", Project Code IP.1.1.03.0040, is currently launched.
Sartorius Croatia - Libra Elektronik d.o.o., in collaboration with its partners, the University of Zagreb School of Medicine, Genera Istraživanja d.o.o., and the Dental Clinic Dario Bekavac, launched the implementation of the project "Research and Development of an Advanced Formulation for Alveolar Ridge Augmentation - OSTEOproDENT" on January 13, 2025.
The project is being carried out in accordance with the rules of the Call for Proposals for Grant Allocation "Strengthening Strategic Partnerships for Innovation in the Process of Industrial Transition", within the Integrated Territorial Program.
The Managing Authority (MA) is the Ministry of Regional Development and EU Funds, while the Intermediate Body for Implementation of Operations (IBIO) is the Croatian Agency for SMEs, Innovations, and Investments.
Project Holder
Sartorius Croatia - Libra Elektronik d.o.o.
Partners
University of Zagreb, School of Medicine
Genera Istraživanja d.o.o.
Dario Bekavac Dental Clinic
Total Project Value and EU Co-financing Amount
Project Implementation Period
January 13, 2025 – January 12, 2028
Project Manager and Contact Person: Josipa Smoljo Marušić
Email: josipa.marusic@sartorius.hr
Phone: +385 1 3340 290
Project Summary
The project addresses the issue of inadequate bone tissue regeneration in dental medicine, a significant challenge in dental implant placement. The goal of the project is to develop an autologous substitute for dental bone grafts.
The project will be implemented within the SPIN consortium, contributing to the region's industrial transition towards an advanced healthcare industry, fostering innovation and competitiveness in Northern Croatia.
Project Description
This project aims to tackle the problem of limited bone tissue regeneration in dental medicine, which hinders successful dental implant placement. The primary objective is to develop an innovative autologous bone tissue substitute, enabling safer and more efficient alveolar ridge regeneration while reducing the need for complex surgical procedures.
The project includes the research and development of a minimally invasive therapy for alveolar ridge augmentation using a personalized formulation.
To ensure successful implementation, the SPIN consortium was established, bringing together experts from various fields to achieve the project’s research objectives.
The research will span 36 months and will be divided into two main phases:
This project will have a significant impact on the research community, dental medicine, and the industrial transition in Northern Croatia.
The results will be published in relevant scientific journals and presented at international conferences, increasing the visibility of Croatian research capacities in biomedicine and dental medicine.
Long-term Benefits
In the long run, the project will provide tangible benefits for dental professionals, patients, and researchers, reducing the need for invasive procedures and improving the outcomes of dental treatments.
Links:
The content of this website is the sole responsibility of Sartorius Croatia - Libra Elektronik d.o.o. The views and opinions expressed are those of the author only and do not necessarily reflect the official position of the European Union or the European Commission. Neither the European Union nor the European Commission can be held responsible for them.